Related Experiment Video
Updated: Jul 13, 2025
00:06
Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
Published on: August 20, 2019
15.3K
PPARγ in Atherosclerotic Endothelial Dysfunction: Regulatory Compounds and PTMs
Jinwen Luan1, Xiaohui Ji1, Longhua Liu1
1School of Exercise and Health, Shanghai University of Sport, Shanghai 200082, China.
International Journal of Molecular Sciences
|October 14, 2023
Summary
Peroxisome proliferator-activated receptor-gamma (PPARγ) is crucial for endothelial function and may treat atherosclerosis. This review explores PPARγ
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Endocrinology
Background:
- Atherosclerosis, a major cause of cardiovascular disease, involves endothelial dysfunction.
- Peroxisome proliferator-activated receptor-gamma (PPARγ) is vital for maintaining endothelial function.
- The precise role of PPARγ in endothelial dysfunction remains unclear.
Purpose of the Study:
- To review the mechanisms of PPARγ in regulating endothelial function.
- To explore the impact of PPARγ regulatory compounds and post-translational modifications (PTMs).
- To assess the therapeutic potential of targeting endothelial PPARγ for atherosclerosis.
Main Methods:
- Literature review of studies on PPARγ, endothelial function, and atherosclerosis.
- Analysis of mechanisms of action for PPARγ modulators.
- Examination of PTMs affecting PPARγ activity.
Main Results:
- PPARγ plays a protective role in endothelial cells.
- Regulatory compounds and PTMs significantly influence PPARγ's control over endothelial function.
- Endothelial PPARγ is a promising target for atherosclerosis treatment.
Conclusions:
- Understanding PPARγ mechanisms is key to developing new atherosclerosis therapies.
- Targeting endothelial PPARγ offers a potential strategy for preventing and treating cardiovascular disease.
- Further research into PPARγ modulators and PTMs is warranted.
Related Concept Videos
01:30Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
01:26Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
01:31Transducer Mechanism: Nuclear Receptors
1.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.4K
02:04Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
01:30Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
01:09GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K